Palisade Bio, Inc. (PALI) vs TriSalus Life Sciences, Inc. (TLSI)
A side-by-side comparison of Palisade Bio, Inc. and TriSalus Life Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PALI
Palisade Bio, Inc.
$1.49HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TLSI
TriSalus Life Sciences, Inc.
$4.27HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — PALI vs TLSI
growth of $100 · dividends reinvested · last 6yPALI -100.0% (-75.4%/yr)TLSI -58.4% (-13.6%/yr)TLSI compounded faster over this window
Log scale — wide-divergence pair
PALI TLSI
PALI vs TLSI: by the numbers
- •TLSI is the larger company ($263M vs $259M market cap).
- •Both run net losses; TLSI's is the smaller (-62.59% vs -6388.20% net margin).
Metrics side by side
Valuation
| Metric | PALI | TLSI |
|---|---|---|
| P/S ratio | 517.27 | 5.83 |
| P/B ratio | 2.12 | 40.14 |
Profitability
| Metric | PALI | TLSI |
|---|---|---|
| Gross margin | 0.00% | 85.79% |
| Operating margin | 0.00% | -59.68% |
| Net margin | -6388.20% | -62.59% |
| ROE | -26.24% | -430.72% |
| ROIC | -28.96% | -59.50% |
Growth (annualized)
| Metric | PALI | TLSI |
|---|---|---|
| Total return CAGR (5Y) | -76.02% | -15.05% |
Frequently asked
- How have PALI and TLSI total returns compared?
- Over the past 5 years, PALI delivered -76.02% and TLSI delivered -15.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.